Sangamo loses Nasdaq listing appeal after minimum bid price breach
Sangamo Therapeutics ends Ernst & Young as auditor after Chapter 11 filing
Sangamo amends 8-K to file asset purchase agreement exhibits
Sangamo Bankruptcy Puts Gene Therapy Platforms In Play, Eli Lilly And Astellas Circle
Sangamo Therapeutics Sets Stalking Horse Sales: $50M to Eli Lilly, Up to $50M to Astellas
Sangamo lines up up to $30 million debtor-in-possession loan from Northridge ATM amid Chapter 11 filing